Prominent physicist loses paper over data falsification

A paper by a promising nanotechnologist has been retracted for data falsification.

Dmitri Lapotko, a Belarusian researcher with a background in laser weaponry, made a name for himself at Rice University in Houston, where he studied the use of nanotechnology to diagnose and treat human diseases. That work earned him significant press coverage, including stories in the New York Times and Science.

But that nanobubble may be bursting. The journal Theranostics has retracted a 2011 paper on which Lapotko is the last and corresponding author, citing questions over data falsification. What’s more, another journal has warned readers there may be a problem with a figure in a 2012 paper on which Lapotko is listed as last author.

Lapotko has since left Rice for Masimo Corp., a developer of monitoring devices for patients in the operating room.

According to the Theranostics notice:

Continue reading Prominent physicist loses paper over data falsification

Cancer researcher has dodged accusations for decades (and has a new correction)

Today isn’t a great day for Carlo Croce, chair of the department of cancer biology and genetics at The Ohio State University (OSU).

The New York Times has a lengthy article detailing the misconduct accusations that have swirled around Croce for years. We’ve covered many, but The Gray Lady obtained documents that show there have been many more.

The story mentions a 2013 letter from Ohio State University to pseudonymous whistleblower Clare Francis (which we reported on in 2014), acknowledging Francis’s allegations against Croce. However, in the letter, an administrator said OSU saw no reason to investigate Croce.

The story didn’t stop there, as the Times reports:

Continue reading Cancer researcher has dodged accusations for decades (and has a new correction)

“Hindsight’s a bitch:” Colleagues dissect painful retraction

Two blog posts are shining additional light on a recent retraction that included some unanswered questions — namely, the identity of the researcher who admitted to manipulating the results.

To recap: Psychological Science recently announced it was retracting a paper about the relationship between the words you use and your mood after a graduate student tampered with the results. But the sole author — William Hart, an assistant professor at the University of Alabama — was not responsible.

The post raised some questions — for instance, who was the graduate student, and if his or her work was so influential to a paper, why was he/she not listed as an author? Hart declined to identify the student, but two new blogs — including one by one of Hart’s collaborators at the University of Alabama — are providing more details.

Continue reading “Hindsight’s a bitch:” Colleagues dissect painful retraction

3rd retraction appears for fired Pfizer breast cancer researcher

Pfizer has retracted a paper by a former employee who was fired after the company discovered she had been doctoring data.

The retraction, in Molecular Cancer Research, is the third of five papers Pfizer asked to retract, after an investigation discovered they contained duplicated images. The papers have been discussed on PubPeer, which is also mentioned in the latest retraction notice.

As a result of the investigation, Pfizer terminated the employment of Min-Jean Yin, the last author on the newly retracted paper.

According to the notice, Yin and five of her co-authors agreed to the retraction:

Continue reading 3rd retraction appears for fired Pfizer breast cancer researcher

Researcher who lost whistleblower lawsuit logs 4 more retractions

A brain journal has retracted four papers by a researcher due to image duplications that the university uncovered during an investigation into his work.

According to the retraction notice, Wayne State University found that Christian Kreipke had used several images in these articles “to represent different results in grant proposals and/or poster presentations,” and that the data were unreliable. Kreipke now has a total of five retractions, by our count.

As we’ve reported before, Wayne State and Kreipke have been engaged in conflict for several years. In 2012, Kreipke was dismissed from his assistant professor post at Wayne State after the university said it found evidence of research misconduct, according to Courthouse News. Kreipke fired back against the university, filing a whistleblower lawsuit. In it, Kreipke claimed that the institution was “involved in a conspiracy,” according to unsealed court documents, in which it had swindled the U.S. government out of millions in research funding.

A judge dismissed the case in 2014, but the conflict between Kreipke and Wayne State was not over. Continue reading Researcher who lost whistleblower lawsuit logs 4 more retractions

Unexplained abnormalities in stem cells prompt Columbia researchers to pull diabetes paper

Researchers at Columbia University have retracted a 2013 paper in The Journal of Clinical Investigation, after uncovering abnormalities in the stem cell lines that undermined the conclusions in the paper.

Last year, corresponding author Dieter Egli discovered he could not reproduce key data in the 2013 paper because almost all the cell lines first author Haiqing Hua used contained abnormalities, casting doubt on the overall findings. When Egli reached out to Hua for answers, Hua could not explain the abnormalities. As a result, Hua and Egli agreed the paper should be retracted.

Since some of the details of how the paper ended up relying on abnormal cells remain unclear, the university confirmed to us that it is investigating the matter.

Here’s the retraction notice for “iPSC-derived β cells model diabetes due to glucokinase deficiency,” cited 42 times: Continue reading Unexplained abnormalities in stem cells prompt Columbia researchers to pull diabetes paper

Authors couldn’t find a patient to give consent for case report. Then the patient found the report.

When a group of authors decided to write up a curious case of a 35-year-old woman with a mysterious mass that took 11 years to be diagnosed, they tried repeatedly to contact the patient for her permission. When they couldn’t reach her, they published the paper anyway, removing any identifiable information.

But the report apparently included enough details for the patient to recognize herself — and when she read the paper, she asked the authors to retract it.

That’s the story according to the publisher of the 2016 case study, which recently retracted it with this notice:

Continue reading Authors couldn’t find a patient to give consent for case report. Then the patient found the report.

Neuroscientist flags errors in his days-old paper “for the sake of science integrity”

Only days after his paper was published online, a neuroscientist has posted a comment on PubMed alerting readers to several duplication errors.

Despite the issues, which the researcher says were introduced into the final manuscript after peer review, he reassured readers that they do not influence the final conclusions in the paper.

On February 9, ten days after the article came online, corresponding author Garret Stuber at the University of North Carolina at Chapel Hill wrote a detailed comment on PubMed Commons, explaining that the “research community” had brought four figure-related errors to his attention. After investigating the concerns, Stuber discovered that the problems emerged after the peer-review process, “while revising the manuscript to comply with Nature Neuroscience’s final formatting guidelines.” In his note, he outlined the specific duplication issues that arose, which he says he plans to detail to the journal in a formal corrigendum letter.

Stuber alerted the scientific community about his PubMed comment via Twitter: Continue reading Neuroscientist flags errors in his days-old paper “for the sake of science integrity”

“False” results in retracted paper by senator are inaccurate, not fraudulent, say editors

Daniel Biss

Last week, we wrote about a somewhat remarkable retraction, of a 15-year-old paper by a current Illinois senator who used to be a mathematician. At the time, we were a bit perplexed by the language of the notice, which the senator — who helpfully took our call — couldn’t answer, since he wasn’t involved in drafting the notice.

We’ve since heard back from the journal that retracted the paper, which explained that their phrase that “most results are false” meant the findings by state senator Daniel Biss were inaccurate — not fraudulent.

Here’s more explanation from a joint statement sent to us by Jan van Mill and Jerry Vaughan, the editors in chief of Topology and its Applications:

Continue reading “False” results in retracted paper by senator are inaccurate, not fraudulent, say editors

Former postdoc admitted to fraud in cell bio paper, lead author says

A researcher in Switzerland has retracted her 2015 paper in the Journal of Cell Biology, saying the first author — her former postdoc — admitted to fabricating multiple aspects of the paper.

After Sophie Martin of the University of Lausanne couldn’t reproduce the data from another manuscript she was preparing to submit, she contacted her former student, Pranav Ullal, who admitted he had fabricated the data, along with two figures in the JCB paper.

A spokesperson for the University of Lausanne told us that Ullal left Switzerland after his contract was over, and is now in India.

Martin told us the whole experience has been upsetting:

Continue reading Former postdoc admitted to fraud in cell bio paper, lead author says